The rejection of Ambipar’s public share purchase offer (OPA), pronounced by the CVM board of directors in July, is not the last chapter in the investigation into possible manipulation of the company’s share price. The regulator’s technical services have resumed investigations and the matter could potentially become sanction proceedings. The information was initially given by the newspaper “Folha de S. Paulo” and confirmed by Value.
About The Author
